Actonel in a monthly dosage of 75mg when taken for 2 consecutive days is as effective and safe as Actonel at a dosage of 5mg taken daily, showed a study published in the recent edition of the Osteoporosis International. The researchers note that since patients with chronic diseases do not always follow the long-term treatment, the focus in clinical practice should be given to a careful fulfillment of the requirements for drugs administration by patients.
According to the study, this factor is affected by the frequency of the medicine intake. Currently Actonel is available in weekly and monthly dosage. The proven effectiveness of the treatment is another important factor influencing the preferences of patients. The researchers believe that the monthly drug administration, effectively reducing the risk of vertebral, non-vertebral and hip fractures, will allow a doctor to offer patients, satisfying all the criteria, a new type of treatment.
Related posts: